Table 1.
Stakeholder categorization for diagnostics co-creation.
| Category | Characteristics |
|---|---|
| 1 | Persons/parents of children who have been previously diagnosed and or treated for S. haematobium infection within the last 3 years. |
| 2 | Stakeholders within the community that can impact the patient's decision to access care (diagnostics, and or treatment). |
| 3 | Stakeholders within the formal health system (both public and private) who can diagnose and or treat patients with schistosomiasis. |
| 4 | Stakeholders within the government who are in charge of programs/processes to identify, and or treat schistosomiasis. |
| 5 | Stakeholders in Non-Governmental Organizations (NGOs) that contribute to schistosomiasis diagnosis, and or treatment within the state. |
| 6 | Stakeholders in academia who are working in the Neglected Tropical Disease field. |
| 7 | Stakeholders that finance diagnosis and or treatment of Neglected Tropical Diseases. |